Example: Heart Attack

Clinical Trials Sponsored by Johnson & Johnson

Total 1242 results

NCT00639353

Terminated

Silicone Hydrogel Contact Lenses on Low Astigmatism in Japan

Conditions: Refractive Error; Myopia; Astigmatism
NCT00986102

Completed

PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region

Conditions: Pneumonia; Pneumonia, Ventilator-Associated; Urinary Tract Infections
NCT03224403

Completed

Randomized, Double-Blind, Single-Dose, Efficacy and Safety Study of Test Acetaminophen Tablet in Postoperative Dental Pain

Conditions: Post-operative Dental Pain
NCT02735122

Completed

Study of Acetaminophen (ACM) in Post-operative Dental Pain

Conditions: Post Operative Dental Pain
NCT02320708

Completed

Study of Acetaminophen (ACE) in Post-operative Dental Pain

Conditions: Dental Pain
NCT01226459

Completed

Clinical Trial in Females for Female Pattern Hair Loss

Conditions: Androgenetic Alopecia
NCT01155323

Completed

Two Week Cross-Over Study Comparing Two Daily Disposable Contact Lenses

Conditions: Myopia
NCT03563742

Recruiting

A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection

Conditions: Human Immunodeficiency Virus Infections
NCT01323491

Completed

"EASY EFFECTIVE SMOKELESS" With NICORETTE®

Conditions: Stereotyped Behavior; Tobacco Smoking Behavior
NCT03264677

Completed

An 8-week Full Face HUT Clinical Trial for HydroBoost (2.0/3.0)

Conditions: Adult Skin Healthy Signs
NCT04288778

Recruiting

A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes

Conditions: Diabetes Mellitus
NCT02691520

Completed

Epidemiology of Treatment Resistant Depression in Taiwan

Conditions: Depressive Disorder, Treatment-Resistant
NCT03768960

Recruiting

A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent

Conditions: Multiple Myeloma
NCT03733925

Recruiting

A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis

Conditions: Spondylitis, Ankylosing; Arthritis, Psoriatic
NCT03604224

Completed

A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting

Conditions: Diabetes Mellitus, Type 2
NCT03476655

Completed

Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India

Conditions: Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell
NCT03190330

Recruiting

A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion

Conditions: Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell
NCT02268890

Completed

A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma

Conditions: Multiple Myeloma
NCT01880294

Completed

A Study to Assess Different Diagnostic Criteria of Chronic Constipation in Asia

Conditions: Constipation
NCT02608359

Recruiting

A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer

Conditions: Prostate Cancer
NCT01689649

Completed

A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy

Conditions: Epilepsy
NCT01677598

Completed

A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries

Conditions: Plaque Psoriasis
NCT01527305

Completed

A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia

Conditions: Schizophrenia
NCT01801436

Completed

A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma

Conditions: Multiple Myeloma
NCT01670071

Terminated

A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia

Conditions: Schizophrenia